Skip to main content
Log in

Hormone Receptors in Breast Cancer: Racial Differences in Distribution and Survival

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The purpose of this study was to describe hormone receptor status and analyze the effect of receptors on survival from breast cancer. Comparisons were made between African–American and Caucasian racial categories. Breast cancer data from 1990 through 1997 collected by the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program were analyzed. Subjects were 993 Caucasian men, 12,303 African–American women, and 141,045 Caucasian women. The number of African–American men was too small to analyze separately (n = 93). In addition to analysis of estrogen and progesterone receptor status by sex and race, tumor and patient characteristics included age, stage at time of diagnosis, and tumor histology. The proportion of Caucasian men with hormone receptor positive tumors remained relatively high and stable for all ages. In women, the proportion of hormone receptor positive tumors increased with age, with African–American women having the highest proportion of hormone receptor negative tumors. Caucasian men had highest proportions of hormone receptor positive tumors in all histology and stage groups, while African–American women had lowest proportions of hormone receptor positive tumors in all stage and histologic categories. Survival for African–American women was significantly worse for each hormone receptor category. In multivariate analyses, race was a significant independent predictor of survival, but sex was not. Although reasons for differences in hormone receptor status by sex and race are unknown, several hypotheses are discussed with respect to differences in tumor histopathology and risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics 2000. CA Cancer J Clin 50: 7–33, 2000

    Google Scholar 

  2. Parker SL, Johnston KJ, Wingo PA, Ries LAG, Health CW: Cancer statistics by race and ethnicity. CA Cancer J Clin 48: 31–48, 1998

    Google Scholar 

  3. Dignam JJ: Differences in breast cancer prognosis among African–American and Caucasian women. CA Cancer J Clin 50: 50–64, 2000

    Google Scholar 

  4. Joslyn SA, West MM: Racial differences in breast carcinoma survival. Cancer 88: 114–123, 2000

    Google Scholar 

  5. Joslyn SA, Gesme DH, Lynch CF: Estrogen and progesterone receptors in primary breast cancer. Breast J 2: 187–196, 1996

    Google Scholar 

  6. Willsher PC, Leach IH, Ellis IO, Bourke JB, Blarney RW, Robertson JFR: A comparison outcome of male breast cancer with female breast cancer. Am J Surg 173: 185–188, 1997

    Google Scholar 

  7. Gattuso P, Reddy L, Green M, Castelli M, Haley D, Herman C: 'New' prognostic factors in invasive breast cancer in men. Modern Pathol 5(1): Abstract No. 69; 13A, 1992

    Google Scholar 

  8. Fox SB, Rogers S, Day CA, Underwood JCE: Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma. J Pathol 166: 13–18, 1992

    Google Scholar 

  9. Stalsberg H, Thomas DB, Rosenblatt KA, Jimenex LM, McTiernan A, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF: Histologic types and hormone receptors in breast cancer in men: a population based study in 282 United States men. Cancer Causes Control 4: 143–151, 1993

    Google Scholar 

  10. Rogers S, Day CA, Fox SB: Expression of cathepsin D and estrogen receptors in male breast carcinoma. Hum Pathol 24: 148–151, 1993

    Google Scholar 

  11. Everson RB, Lippman ME, Thompson EB, McGuire WL, Wittliff JL, De Sombre ER, Jensen EV, Singhakowinta A, Brooks SC, Neifeld JP: Clinical correlation of steroid receptors and male breast cancer. Cancer Res 40: 991–997, 1980

    Google Scholar 

  12. Pacheco M, Oshima CF, Lopes MP, Widman A, Franco LL, Brentani MM: Steroid hormone receptors in male breast diseases. Anticancer Res 6: 1013–1018, 1986

    Google Scholar 

  13. Wolff M, Reinis MS: Breast cancer in the male: clinicopathological study of 40 patients and review of the literature. In: Fenoglio CM, Wolff M (eds) Progress in Surgical Pathology. Vol 3, Masson, New York, 1981, pp 77–109

    Google Scholar 

  14. Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK: Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272: 947–954, 1994

    Google Scholar 

  15. Gordon NH, Crowe JP, Brumberg DJ, Berger NA: Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 135: 609–618, 1992

    Google Scholar 

  16. Kovi J, Mohla S, Norris HJ, Sampson CC, Heshmat MY: Breast lesions in black women. Pathol Annu 24: 199–218, 1989

    Google Scholar 

  17. Elledge RM, Clark GM, Chamness GC, Osborne CK: Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86: 705–712, 1994

    Google Scholar 

  18. Pegoraro RJ, Nirmul D, Reinach SG, Jordaan JP, Joubet SM: Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status. Breast cancer Res Treat 7: 111–118, 1986

    Google Scholar 

  19. Pegoraro RJ, Karnan V, Nirmul D, Joubert SM: Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res 46: 2117–2120, 1986

    Google Scholar 

  20. Beverly LN, Flanders WD, Go RC, Soong SJ: A comparison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Public Health 77: 351–353, 1987

    Google Scholar 

  21. Stanford J, Greenberg R: Breast cancer incidence in young women by estrogen receptor status and race. Am J Public Health79: 71–73, 1989

    Google Scholar 

  22. Wittliff JL: Steroid hormone receptors in breast cancer. Cancer 53: 630–643, 1984

    Google Scholar 

  23. Hawkins RA, Roberts MM, Forrest APM: Oestrogen receptors and breast cancer: current status. Br J Surg 67: 153–169, 1980

    Google Scholar 

  24. Morabia A, Flandre P: Misclassification bias related to definition of menopausal status in case-control studies of breast cancer. Int J Epidemiol 21: 222–227, 1992

    Google Scholar 

  25. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481, 1958

    Google Scholar 

  26. Cox DR: Regression models and life tables. J Stat Soc B 34: 187–220, 1972

    Google Scholar 

  27. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ: Prognostic factors in breast cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7): 966–978, 2000

    Google Scholar 

  28. Salvadori B, Saccozzi R, Manzari A, Andreola S, Conti RA, Cusumano F, Grassi M: Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 30A: 930–935, 1994

    Google Scholar 

  29. Heller KS, Rosen PP, Schottenfeld D, Ashikari R, Kinne DW: Male breast cancer: a clinicopathologic study of 97 cases. Ann Surg 188: 60–65, 1978

    Google Scholar 

  30. Lundy J, Mishriki Y, Viola MV, Chao S, Kasa B, Oraves S, Schuss A: A comparison of tumor-related antigens in male and female breast cancer. Breast Cancer Res Treat 7: 91–96, 1986

    Google Scholar 

  31. Ravandi-Kashani F, Hayes TG: Male breast cancer: a review of the literature. Eur J Cancer 34(9): 1341–1347, 1998

    Google Scholar 

  32. Appleqvist P, Salmo M: Prognosis in carcinoma of the male breast. Acta Chir Scand148: 499–502, 1982

    Google Scholar 

  33. Ribeiro GG: Male breast carcinoma: 'a review of 301 cases from the Christie Hospital and Holt Radium Institute, Manchester. Br J Cancer 51: 115–119, 1985

    Google Scholar 

  34. Robinson FW, Farha GC: Carcinoma of the male breast. Am J Surg 113: 394–400, 1967

    Google Scholar 

  35. Roswell B, Edlis H. Carcinoma of the male breast: a thirtyyear experience and literature review. Int J Radiat Oncol Biol Phys 4: 711, 1978

    Google Scholar 

  36. Borgen P, Wong GY, Vlamis V, Potter C, Hoffmann B, Kinne DW, Osborne MP, KcKinnon WM: Current management of male breast cancer. Ann Surg 215: 451–458, 1992

    Google Scholar 

  37. Sandler B, Carman C, Perry RR: Cancer of the male breast. Ann Surg 60(11): 816–820, 1994

    Google Scholar 

  38. Digenis AG, Ross CB, Morrison JG, Holcomb GW, Reynolds VH: Carcinoma of the male breast: a review of 41 cases. South Med J 83: 1162–1167, 1990

    Google Scholar 

  39. Wainright JM. Carcinoma of the male breast. Arch Surg 14: 836–859, 1927

    Google Scholar 

  40. Vercoutre AL, O'Connell TX: Carcinoma of the male breast: an update. Arch Surg 119: 1301–1304, 1984

    Google Scholar 

  41. Guinee VF, Olsson H, Moller T, Shallenberger RC, van den Blink JW, Peter Z, Durand M, Dische S: The prognosis of breast cancer in men: a report of 335 cases. Cancer 71: 154–161, 1993

    Google Scholar 

  42. Vettov J, Jun SY, Padduch D, Eppich H, Shis R: Stage at presentation, prognostic factors, and outcome of breast cancer in males. Am J Surg 177(5): 379–383, 1999

    Google Scholar 

  43. Donegan WL, Redlich PN, Lang PH, Gall MT: Carcinoma of the breast in males: a multi-institutional survey. Cancer 83(3): 498–509, 1998

    Google Scholar 

  44. Borgen PI, Senie RT, McKinnon WM, Rosen PP: Carcinoma of the male breast: analysis and prognosis compared with matched female patients. Ann Surg Oncol 4(5): 385–388, 1997

    Google Scholar 

  45. Fox SB, Rogers S, Day CA, Underwood JCE: Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma. J Pathol 166: 13–18, 1992

    Google Scholar 

  46. Willsher PC, Leach IH, Ellis IO, Bell JA, Elston CW, Bourke JB, Blarney RW, Robertson JF: Male breast cancer: pathological and immunohistochemical features. Anticancer Res 17: 2335–2338, 1997

    Google Scholar 

  47. Tan PH, Sng IT: Male breast cancer: a retrospective study with immunohistochemical analysis of hormone receptor expression. Pathology 29(1): 2–6, 1997

    Google Scholar 

  48. Cutuli B, Lacroze M, Dilhuydy JM, Velten M, De Lafontan B, Marchal C, Resbeut M, Graic Y, Campana F, Moncho-Bernier V: Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 31A(12): 1960–1964, 1995

    Google Scholar 

  49. Yogore M, Sahgal S: Small cell carcinoma of the male breast: report of a case. Cancer 39: 1748–1751, 1997

    Google Scholar 

  50. Sanchez AG, Villanueva AG, Redondo C: Lobular carcinoma of the breast in a patient with Klinefelter's syndrome: a case with bilateral, synchronous, histologically different breast tumors. Cancer 57: 1181–1183, 1986

    Google Scholar 

  51. Norris HJ, Taylor HB: Carcinoma of the male breast. Cancer 23: 1428–1435, 1969

    Google Scholar 

  52. Haagensen CD: Diseases of the Breast. 2nd edn, PA: Saunders, Philadelphi, 1971

    Google Scholar 

  53. Giffler RF, Kay S: Small-cell carcinoma of the male mammary gland: a tumor resembling infiltrating lobular carcinoma. Am J Clin Pathol 66: 715–722, 1976

    Google Scholar 

  54. Stalsberg H, Thomas DB, Noonan EA and The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. Int J Cancer 44: 399–409, 1989

    Google Scholar 

  55. Bannayan GA, Hajdu SI: Gynecomastia: clinicopathologic study of 351 cases. Am J Clin Pathol 57: 431–437, 1972

    Google Scholar 

  56. Reiner A, Reiner G, Spona J, Schemper M, Holzner JH: Histopathologic characteristics of human breast cancer in correlation with estrogen receptor status: a comparison of immunocytochemical and biochemical analysis. Cancer 61: 1149–1154, 1988

    Google Scholar 

  57. Mohammed RH, Lakatua DJ, Haus E, Yasmineh WJ: Estrogen and progesterone receptors in human breast cancer: correlation with histologic subtypes and degree of differentiation. Cancer 58: 1076–1081, 1986

    Google Scholar 

  58. Silfversward C, Gustafsson J-A, Gustafsson SA, Nordenskjold B, Wallgren A, Wrange O: Estrogen receptor concentration in 269 cases of histologically classified human breast cancer. Cancer 45: 2001–2003, 1980

    Google Scholar 

  59. Burns RB, McCarthy EP, Freund KM, Marwill SL, Shwartz M, Ash A, Muskowitz MA: Black women receive less mammography even with similar use of primary care. Ann Intern Med 125: 173–182, 1996

    Google Scholar 

  60. Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS: Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 279: 1801–1807, 1998

    Google Scholar 

  61. Howard DL, Penchansky R, Brown MB: Disaggregating the effects of race on breast cancer survival. Fam Med 30: 228–235, 1998

    Google Scholar 

  62. Miller AM, Champion VL: Attitudes about breast cancer and mammography: racial, income, and educational differences. Women Health26: 41–63, 1997

    Google Scholar 

  63. Simon MS, Severson RK: Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer 77: 308–314, 1996

    Google Scholar 

  64. Simon MS, Severson RK: Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology. Am J Obstet Gynecol 176: S233–S239, 1997

    Google Scholar 

  65. Greenwald HP, Polissar NL, Dayal HH: Race, socioeconomic status, and survival in three female cancers. Ethn Health 1: 65–75, 1996

    Google Scholar 

  66. Edwards MJ, Gamel JW, Vaughan WP, Wrightson WR: Infiltrating ductal carcinoma of the breast: the survival impact of race. J Clin Oncol 16: 2693–2699, 1998

    Google Scholar 

  67. Lyman GH, Kuderer NM, Lyman SL, Cox CE, Reintgen D, Baekey P: Importance of race on breast cancer survival. Ann Surg Oncol 4: 80–87, 1997

    Google Scholar 

  68. Ragland KE, Selvin S, Merrill DW: Black/white differences in stage-specific cancer survival: analysis of seven selected sites. Am J Epidemiol 133: 672–682, 1991

    Google Scholar 

  69. Coates RJ, Clark WS, Eley JW, Greenberg RS, Huguley CM, Brown RL: Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst 82: 1684–1692, 1990

    Google Scholar 

  70. Joslyn SA, Pomrehn PR, Lynch CF: Racial differences in breast cancer survival in Iowa. Breast J1: 350–355, 1995

    Google Scholar 

  71. Heimann R, Ferguson D, Powers C, Suri D, Weichselbaum RR, Hellman S: Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol 15: 2329–2337, 1997

    Google Scholar 

  72. Perkins P, Cooksley CD, Cox JD: Breast cancer. Is ethnicity an independent prognostic factor for survival? Cancer 78: 1241–1247, 1996

    Google Scholar 

  73. Franzini L, Williams AF, Franklin J, Singletary SE, Theriault RL: Effects of race and socioeconomic status on survival of 1,332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol 4: 111–118, 1997

    Google Scholar 

  74. Roach M, Cirrincione C, Budman D, Hayes D, Berry D, Younger J, Hart R, Henderson IC: Race and survival from breast cancer: based on Cancer and Leukemia Group B Trial 8541. Cancer J Sci Am 2: 107–112, 1997

    Google Scholar 

  75. Natarajan N, Nemoto T, Mettlin C, Murphy GP: Race-related differences in breast cancer patients: results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer 56: 1704–1709, 1985

    Google Scholar 

  76. Freeman HP, Wasfie TJ: Cancer of the breast in poor black women. Cancer 63: 2562–2569, 1989

    Google Scholar 

  77. Chang S, Parker SL, Pham T, Buzdar AU, Jursting SD: In-flammatory breast carcinoma incidence and survival. The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute, 1975–1992. Cancer 82: 2366–2372, 1998

    Google Scholar 

  78. Krieger N, Van Den Eeden SK, Zava D, Okamoto A: Race/ethnicity, social class, and prevalence of breast cancer prognostic biomarkers: a study of white, black, and Asian women in the San Francisco Bay area. Ethnicity Dis 7: 137–149, 1997

    Google Scholar 

  79. Weiss SE, Tartter PI, Ahmed S, Brower ST, Brusco C, Bossolt K, Amerson JB, Bratton J: Ethnic differences in risk and prognostic factors for breast cancer. Cancer 76: 268–274, 1995

    Google Scholar 

  80. Ownby HE, Frederick J, Russo J, Brooks SC, Swanson GM, Heppner GH, Brennan MJ: Racial differences in breast cancer patients. J Natl Cancer Inst 75: 55–60, 1985

    Google Scholar 

  81. Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP: Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women: an analysis of 13,239 cases. Cancer 77(8): 1465–1471, 1996

    Google Scholar 

  82. Mohla S, Sampson CC, Khan T, Enterline JP, Leffall L, White JE: Estrogen and progesterone receptors in breast cancer in black Americans. Cancer 50: 552–559, 1982

    Google Scholar 

  83. Yoo K-Y, Tajima K, Miura S, Takeuchi T, Hirose K, Risch H, Dubrow R: Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol 146: 307–314, 1997

    Google Scholar 

  84. Kreiger N, King WD, Rosenberg L, Clarke EA, Palmer JR, Shapiro S: Steroid receptor status and the epidemiology of breast cancer. Ann Epidemiol 1: 513–523, 1991

    Google Scholar 

  85. McTiernan A, Thomas DB, Johnson LK, Roseman D: Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers. J Natl Cancer Inst 77: 849–854, 1986

    Google Scholar 

  86. Hildreth NG, Kelsey JL, Eisenfeld AJ, LiVolsi VA, Holford TR, Fischer DB: Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. H Natl Cancer Inst 70: 1027–1031, 1983

    Google Scholar 

  87. Hislop TG, Coldman AJ, Elwood JM, Skippen DH, Kan L: Relationship between risk factors for breast cancer and hormonal status. Int J Epidemiol 15: 469–476, 1986

    Google Scholar 

  88. Jensen EV: Steroid receptors in breast cancer: historical perspective. Cancer 46: 2759–2761, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joslyn, S.A. Hormone Receptors in Breast Cancer: Racial Differences in Distribution and Survival. Breast Cancer Res Treat 73, 45–59 (2002). https://doi.org/10.1023/A:1015220420400

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015220420400

Navigation